Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 2, 2006, Pages 324-330

  Feeney, Margaret E ^a,b   Tang, Yanhua ^a   Rathod, Almas ^a   Kneut, Catherine ^b   McIntosh, Kenneth ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CCR5; CD4 T H cells; cytotoxic T lymphocytes; long term nonprogressor; Perinatal HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; DIDANOSINE; INDINAVIR; RITONAVIR; STAVUDINE; VIRUS ANTIGEN; VIRUS DNA; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MEDICAL LITERATURE; PATHOGENESIS; PERINATAL INFECTION; PERINATAL PERIOD; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIREMIA;

ADOLESCENT; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; VIRAL LOAD; VIREMIA;

EID: 33746564795     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.05.016     Document Type: Article

References (47)

1. Pantaleo G., and Koup R.A. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 10 (2004) 806-810
2. Alexander L., Weiskopf E., Greenough T.C., Gaddis N.C., Auerbach M.R., Malim M.H., et al. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol 74 (2000) 4361-4376
3. Alexander L., Cuchura L., Simpson B.J., and Andiman W.A. Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors. Pediatr Infect Dis J 25 (2006) 135-141
4. Alexander L., Aquino-DeJesus M.J., Chan M., and Andiman W.A. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child. J Virol 76 (2002) 10533-10539
5. Rhodes D.I., Ashton L., Solomon A., Carr A., Cooper D., Kaldor J., et al. Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. J Virol 74 (2000) 10581-10588
6. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332 (1995) 228-232
7. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278 (1997) 1447-1450
8. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldridge R.L., et al. Immune control of HIV-1 after early treatment of acute infection. Nature 407 (2000) 523-526
9. *5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 97 (2000) 2709-2714
10. Migueles S.A., Laborico A.C., Shupert W.L., Sabbaghian M.S., Rabin R., Hallahan C.W., et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3 (2002) 1061-1068
11. Zimmerli S.C., Harari A., Cellerai C., Vallelian F., Bart P.A., and Pantaleo G. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci U S A 102 (2005) 7239-7244
12. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. [published erratum appears in Science 1996;274:1069]. Science 273 (1996) 1856-1862
13. Michael N.L., Louie L.G., Rohrbaugh A.L., Schultz K.A., Dayhoff D.E., Wang C.E., et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 3 (1997) 1160-1162
14. Winkler C., Modi W., Smith M.W., Nelson G.W., Wu X., Carrington M., et al. Genetic restriction of AIDS pathogenesis by an stromal-derived factor 1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279 (1998) 389-393
15. Kostrikis L.G., Huang Y., Moore J.P., Wolinsky S.M., Zhang L., Guo Y., et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4 (1998) 350-353
16. Rizzardi G.P., Morawetz R.A., Vicenzi E., Ghezzi S., Poli G., Lazzarin A., et al. CCR2 polymorphism and HIV disease. Swiss HIV Cohort. Nat Med 4 (1998) 252-253
17. Carrington M., and O'Brien S.J. The influence of HLA genotype on AIDS. Annu Rev Med 54 (2003) 535-551
18. Gonzalez E., Kulkarni H., Bolivar H., Mangano A., Sanchez R., Catano G., et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307 (2005) 1434-1440
19. Learmont J.C., Geczy A.F., Mills J., Ashton L.J., Raynes-Greenow C.H., Garsia R.J., et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med 340 (1999) 1715-1722
20. Pikora C.A., Wittish C., and Desrosiers R.C. p6gag of human and simian immunodeficiency viruses is tolerant to small in-frame deletions downstream of the late domain. Virology 346 (2005) 479-489
21. Williams C.F., Klinzman D., Yamashita T.E., Xiang J., Polgreen P.M., Rinaldo C., et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350 (2004) 981-990
22. Xiang J., Wunschmann S., Diekema D.J., Klinzman D., Patrick K.D., George S.L., et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345 (2001) 707-714
23. Feeney M.E., Draenert R., Roosevelt K.A., Pelton S.I., McIntosh K., Burchett S.K., et al. Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection. J Immunol 171 (2003) 6968-6975
24. Betts M.R., Nason M.C., West S.M., De Rosa S.C., Migueles S.A., Abraham J., et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells. Blood 107 (2006) 4781-4789
25. Gao X., Bashirova A., Iversen A.K., Phair J., Goedert J.J., Buchbinder S., et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 11 (2005) 1290-1292
26. Goulder P.J., Phillips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3 (1997) 212-217
27. Kelleher A.D., Long C., Holmes E.C., Allen R.L., Wilson J., Conlon C., et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 193 (2001) 375-386
28. Feeney M.E., Tang Y., Roosevelt K.A., Leslie A.J., McIntosh K., Karthas N., et al. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol 78 (2004) 8927-8930
29. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381 (1996) 661-666
30. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381 (1996) 667-673
31. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 (1996) 1135-1148
32. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272 (1996) 1955-1958
33. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2 (1996) 1240-1243
34. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996) 367-377
35. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996) 722-725
36. Barroga C.F., Raskino C., Fangon M.C., Palumbo P.E., Baker C.J., Englund J.A., et al. The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment. J Infect Dis 182 (2000) 413-419
37. Misrahi M., Teglas J.P., N'Go N., Burgard M., Mayaux M.J., Rouzioux C., et al. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. JAMA 279 (1998) 277-280
38. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277 (1997) 959-965
39. Romiti M.L., Colognesi C., Cancrini C., Mas A., Berrino M., Salvatori F., et al. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection. Mol Med 6 (2000) 28-36
40. Ioannidis J.P., Contopoulos-Ioannidis D.G., Rosenberg P.S., Goedert J.J., De Rossi A., Espanol T., et al. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis. AIDS 17 (2003) 1631-1638
41. Mangano A., Gonzalez E., Dhanda R., Catano G., Bamshad M., Bock A., et al. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J Infect Dis 183 (2001) 1574-1585
42. Feeney M.E., Roosevelt K.A., Tang Y., Pfafferott K.J., McIntosh K., Burchett S.K., et al. Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children. J Virol 77 (2003) 7492-7501
43. Demirov D.G., Ono A., Orenstein J.M., and Freed E.O. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci U S A 99 (2002) 955-960
44. Colgrove R.C., Millet A., Bauer G.R., Pitt J., and Welles S.L. Gag-p6 Tsg101 binding site duplications in maternal-infant HIV infection. AIDS Res Hum Retroviruses 21 (2005) 191-199
45. Wu L., Paxton W.A., Kassam N., Ruffing N., Rottman J.B., Sullivan N., et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 185 (1997) 1681-1691
46. Lichterfeld M., Kaufmann D.E., Yu X.G., Mui S.K., Addo M.M., Johnston M.N., et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 200 (2004) 701-712
47. Mummidi S., Bamshad M., Ahuja S.S., Gonzalez E., Feuillet P.M., Begum K., et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 275 (2000) 18946-18961